Knee osteoarthritis is the most common reason PRP is requested and one of the indications where the evidence is least settled. That combination is worth understanding before paying for a course of injections.
The account below follows the teaching of Robert Stall, MD, who is board certified in physical medicine and rehabilitation with subspecialty certification in pain medicine.
What PRP is actually doing in an arthritic knee
It is not regrowing cartilage. Nothing in the regenerative category does that.
PRP delivers concentrated platelets whose alpha granules release growth factors, initiating the same three-phase healing sequence that follows prolotherapy: inflammation over one to three days, proliferation from around 72 hours to six weeks with new type I and type III collagen laid down, then remodelling that can continue for up to two years.
In a joint the plausible targets are the soft tissue and the inflammatory environment rather than the cartilage defect itself. Framing it as joint regeneration sets up a disappointment the mechanism cannot avoid.
Which formulation, and why it is specified for knees
Formulation is not incidental here. Stall notes that pure platelet-rich fibrin — P-PRF, with no white blood cells and a high fibrin matrix — is the formulation popular for orthopaedic indications and “particularly osteoarthritis of the knee.”
The reasoning is that leukocytes carry inflammatory potential that may be unhelpful inside a joint, while a high fibrin matrix holds the preparation at the site for longer.
This is a reasonable question to put to a clinic: which formulation are they using for a knee, and why that one.
The concentration question applies here too
Platelet concentrations from above baseline to about 750,000 per microlitre are supported as effective. Above that, Stall states there is “no evidence that platelet concentrations greater than 750,000 necessarily provided any better tissue regeneration in soft tissue injury” — and at very high concentrations the effect on bone regeneration was inhibitory, performing worse than no treatment at all.
A knee is a joint containing bone. A preparation selected for a headline concentration figure is selected against the evidence, not in line with it.
PRP against the alternatives
Versus corticosteroid. The most instructive comparison comes from adhesive capsulitis rather than knee arthritis, but the pattern is informative: corticosteroid produced better short-term pain and function, PRP better long-term reduction in pain and disability. Steroid front-loads relief; PRP, if it works, arrives later and lasts longer.
Versus hyaluronic acid. One comparison found three consecutive PRP injections outperformed both a single PRP injection and a series of three hyaluronic acid injections at six months. Stall reports it with the caveats attached: the single-injection group received two saline injections first for reasons never explained, the sample was small, and the design has not been replicated elsewhere.
That is how the result should be carried — suggestive, not established.
Alpha-2-macroglobulin: the upgrade that did not outperform
A2M is frequently offered as a premium option above standard PRP, so the trial data matters.
A prospective clinical trial at NYU Langone Health randomised 75 patients with symptomatic knee osteoarthritis into three arms: intra-articular steroid, intra-articular traditional PRP, or intra-articular A2M or A2M-enhanced PRP.
The result, as Stall reports it: A2M had similar efficacy to corticosteroid, and was “no better than regular PRP” at six-week and twelve-week follow-up. Published in the Orthopaedic Journal of Sports Medicine.
Worth knowing before accepting a higher price for it.
How many injections for a knee
The honest position is that nobody knows. Stall states it plainly: “the ideal injection regimen remains undefined and there are contradictions within the published literature.”
What is known usefully constrains the schedule. Healing after PRP does not begin until several weeks after injection, so common practice is not to inject more than once a month. Because remodelling continues for a year or longer, there is no contraindication to injecting less frequently than that.
Two intra-articular injections have shown efficacy for knee osteoarthritis in published work. A fixed package of three sold before the first result is known is a commercial decision rather than a clinical one.
What to expect, and when
- Days 1 to 3. Possible pain exacerbation during the inflammatory phase. Not everyone experiences it, but this is when it happens.
- From about 72 hours to six weeks. Proliferation. First improvements in pain and function typically appear here.
- The caution that matters. New collagen at this stage is immature and disorganised, so the knee is at increased injury risk exactly when it starts feeling better. Loading it hard during this window is how results are lost.
- Weeks to months. Remodelling, continuing well beyond the point most people stop counting.
Judging a PRP injection at two weeks judges it during proliferation, before remodelling has done anything.
When PRP is the wrong answer
Bone-on-bone arthritis with no remaining cartilage is the clearest case — there is no structural target for the treatment to act on, and the same limit applies to viscosupplementation, as covered in rooster comb injections.
Equally, a patient wanting guaranteed surgery avoidance is asking for something no trial supports, and a patient who cannot rest the knee through the proliferation phase is unlikely to get the benefit the schedule depends on.
Learn blocks with your hands, not from a page
Empire’s Pain Management Training (THE Pain Show) is accredited for 25.25 AMA PRA Category 1 Credits™, jointly provided by AKH, Inc, and Empire Medical Training. For narrower peripheral work, Joint, Extremity and Non-Spinal Injection Training carries 6.75 credits for the complete in-person hybrid program, and Advanced Musculoskeletal Ultrasound Guided Injections builds the guidance skills above.
Claim Your Prize!